Header Logo

Jennifer Daly

Concepts (209)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Transplantation
6
2021
163
0.880
Why?
Mycoses
4
2012
41
0.630
Why?
Immunocompromised Host
3
2021
91
0.490
Why?
Ascomycota
1
2012
11
0.430
Why?
Bursitis
1
2012
10
0.430
Why?
Knee Injuries
1
2012
47
0.410
Why?
Kidney Transplantation
2
2017
253
0.390
Why?
Tuberculosis
2
2012
250
0.350
Why?
Antitubercular Agents
2
2012
67
0.350
Why?
Anti-Bacterial Agents
5
2000
652
0.300
Why?
Patient Compliance
1
2009
374
0.280
Why?
Imipenem
2
1997
5
0.270
Why?
Microbial Sensitivity Tests
5
2020
166
0.260
Why?
Opportunistic Infections
2
2017
27
0.240
Why?
Pleural Effusion
2
2020
32
0.220
Why?
Ganciclovir
1
2002
18
0.220
Why?
Lithiasis
1
2002
1
0.210
Why?
Actinomycosis
1
2002
2
0.210
Why?
Hemoptysis
1
2002
6
0.210
Why?
Bronchial Diseases
1
2002
7
0.210
Why?
Histoplasmosis
1
2002
23
0.210
Why?
Cytomegalovirus Infections
1
2002
64
0.200
Why?
Bronchi
1
2002
67
0.200
Why?
Antifungal Agents
3
2020
114
0.200
Why?
Lung Diseases
2
2018
145
0.180
Why?
Ampicillin
2
1997
11
0.180
Why?
DNA Polymerase III
1
2000
27
0.180
Why?
Uracil
1
2000
26
0.180
Why?
Gram-Positive Bacteria
1
2000
34
0.180
Why?
Strongyloides stercoralis
1
2020
11
0.180
Why?
Strongyloidiasis
1
2020
9
0.180
Why?
Lymphoma, Mantle-Cell
1
2020
12
0.180
Why?
Stem Cell Transplantation
1
2020
72
0.170
Why?
Antiviral Agents
1
2002
311
0.170
Why?
Enzyme Inhibitors
1
2000
327
0.160
Why?
Drug Therapy, Combination
4
2000
408
0.150
Why?
Lung
1
2002
702
0.150
Why?
Critical Care
2
2020
393
0.150
Why?
Mycobacterium haemophilum
1
2017
5
0.150
Why?
Mycobacterium Infections
1
2017
16
0.150
Why?
Thienamycins
1
1997
1
0.150
Why?
Tobramycin
1
1997
6
0.140
Why?
Penicillins
1
1997
28
0.140
Why?
Gentamicins
1
1997
22
0.140
Why?
Phylogeny
2
2021
318
0.140
Why?
Pseudomonas aeruginosa
1
1997
97
0.140
Why?
Crohn Disease
1
2017
103
0.140
Why?
Endocarditis, Bacterial
2
1993
29
0.130
Why?
Humans
24
2021
57066
0.130
Why?
Middle Aged
10
2021
15410
0.130
Why?
Staphylococcus
2
1999
15
0.120
Why?
DNA, Bacterial
2
2012
250
0.120
Why?
Rickettsiaceae
1
1993
1
0.110
Why?
Rickettsiaceae Infections
1
1993
5
0.110
Why?
Cryptococcosis
2
2008
71
0.110
Why?
Molecular Sequence Data
2
2012
1968
0.100
Why?
Male
12
2021
26218
0.100
Why?
Tuberculosis, Pulmonary
2
2004
104
0.100
Why?
Tissue Donors
1
2012
127
0.100
Why?
Bronchoscopy
2
2020
56
0.090
Why?
HLA-B Antigens
1
2010
14
0.090
Why?
Genes, MHC Class I
1
2010
28
0.090
Why?
Skin Diseases, Infectious
1
1990
9
0.090
Why?
Immunosuppressive Agents
3
2021
279
0.090
Why?
Ultrasonography
1
2012
428
0.090
Why?
HIV-1
2
2010
700
0.090
Why?
Peritonitis
1
1990
34
0.090
Why?
Massachusetts
2
2009
2085
0.090
Why?
Rifampin
1
2009
23
0.090
Why?
Colitis
1
1990
71
0.090
Why?
Isoniazid
1
2009
11
0.090
Why?
Enterococcus faecium
2
2020
6
0.080
Why?
HIV Infections
2
2010
901
0.080
Why?
Amphotericin B
1
2008
22
0.080
Why?
Antibiotic Prophylaxis
1
2008
45
0.080
Why?
Antigen Presentation
1
2010
224
0.080
Why?
Oxazoles
1
1988
10
0.080
Why?
Streptococcus
1
1988
16
0.080
Why?
Triazoles
1
2008
55
0.080
Why?
Organ Transplantation
1
2008
51
0.080
Why?
Diagnosis, Differential
2
2017
851
0.070
Why?
Kidney Failure, Chronic
2
2018
186
0.070
Why?
Treatment Outcome
4
2009
4824
0.070
Why?
Candida
2
2020
34
0.060
Why?
Postoperative Complications
3
2018
1050
0.060
Why?
Time Factors
3
2002
3457
0.060
Why?
Liver
1
2009
749
0.060
Why?
Student Health Services
1
2004
6
0.060
Why?
Communicable Disease Control
1
2004
37
0.060
Why?
Magnetic Resonance Imaging
1
2012
1878
0.060
Why?
Primary Prevention
1
2004
132
0.060
Why?
Aged
4
2020
12583
0.050
Why?
Adult
6
2009
15129
0.050
Why?
Retrospective Studies
3
2020
5651
0.050
Why?
Injections, Intravenous
1
2002
146
0.050
Why?
Incidence
3
2012
1188
0.050
Why?
Female
6
2017
29606
0.050
Why?
Superinfection
1
2002
10
0.050
Why?
Costs and Cost Analysis
1
2002
98
0.050
Why?
Granuloma
1
2002
34
0.050
Why?
Cytomegalovirus
1
2002
84
0.050
Why?
Monitoring, Physiologic
1
2002
143
0.050
Why?
Administration, Oral
1
2002
334
0.050
Why?
Calcinosis
1
2002
78
0.050
Why?
Lymph Nodes
1
2002
208
0.050
Why?
Mycophenolic Acid
1
2021
32
0.050
Why?
Polymerase Chain Reaction
1
2002
486
0.050
Why?
Tacrolimus
1
2021
39
0.050
Why?
Enterococcus
1
2000
9
0.050
Why?
Candidiasis, Invasive
1
2020
9
0.050
Why?
Thiabendazole
1
2020
3
0.050
Why?
Antiparasitic Agents
1
2020
6
0.050
Why?
Tomography Scanners, X-Ray Computed
1
2020
14
0.050
Why?
Daptomycin
1
2020
9
0.050
Why?
Blood Cell Count
1
2020
32
0.050
Why?
Ivermectin
1
2020
10
0.050
Why?
Survival Rate
1
2002
753
0.050
Why?
HIV Long Terminal Repeat
1
2000
12
0.040
Why?
Abdomen
1
2020
92
0.040
Why?
Disease Outbreaks
1
2020
103
0.040
Why?
Aged, 80 and over
1
2009
4814
0.040
Why?
Young Adult
1
2009
4130
0.040
Why?
Pneumonia, Staphylococcal
1
1999
12
0.040
Why?
Methicillin Resistance
1
1999
19
0.040
Why?
Staphylococcus aureus
1
2000
156
0.040
Why?
Candidiasis
2
2008
38
0.040
Why?
Anti-HIV Agents
1
2000
151
0.040
Why?
Dose-Response Relationship, Drug
2
1997
797
0.040
Why?
Pulmonary Atelectasis
1
2018
10
0.040
Why?
Pulmonary Edema
1
2018
22
0.040
Why?
Immunotherapy
1
2020
219
0.040
Why?
Streptomycin
1
1997
12
0.040
Why?
Drug Resistance, Multiple
1
1997
34
0.040
Why?
Gram-Positive Bacterial Infections
1
1997
29
0.040
Why?
Agar
1
1997
3
0.040
Why?
Coronary Artery Bypass
1
1999
255
0.040
Why?
Preoperative Care
1
2018
158
0.040
Why?
Surgical Wound Infection
1
1997
96
0.040
Why?
Fetal Blood
1
1997
71
0.040
Why?
Culture Media
1
1997
78
0.030
Why?
Drug Interactions
1
1997
111
0.030
Why?
Zinc
1
1997
87
0.030
Why?
Intensive Care Units
1
2020
433
0.030
Why?
In Vitro Techniques
1
1997
465
0.030
Why?
Prognosis
1
2020
1478
0.030
Why?
Temperature
1
1997
296
0.030
Why?
Viral Load
2
2010
214
0.030
Why?
Pneumonia
1
2018
259
0.030
Why?
Base Sequence
2
2000
1312
0.030
Why?
Tomography, X-Ray Computed
1
2002
1331
0.030
Why?
Drug Stability
1
1994
137
0.030
Why?
Chromatography, High Pressure Liquid
1
1994
197
0.030
Why?
Drug Resistance, Microbial
2
1997
42
0.030
Why?
Base Composition
1
1993
29
0.030
Why?
Prospective Studies
1
2020
2933
0.030
Why?
RNA, Ribosomal, 16S
1
1993
67
0.030
Why?
RNA, Bacterial
1
1993
67
0.030
Why?
Lactobacillus acidophilus
1
1992
1
0.030
Why?
Infant, Newborn
1
1997
1292
0.030
Why?
Living Donors
1
2012
55
0.030
Why?
Fatty Acids
1
1993
187
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
445
0.020
Why?
HLA-C Antigens
1
2010
3
0.020
Why?
HIV Long-Term Survivors
1
2010
9
0.020
Why?
HLA-A Antigens
1
2010
11
0.020
Why?
HIV Antigens
1
2010
20
0.020
Why?
Haplotypes
1
2010
116
0.020
Why?
Immune Tolerance
1
1990
168
0.020
Why?
Amino Acids
1
2010
141
0.020
Why?
Phenotype
1
1993
1097
0.020
Why?
Alleles
1
2010
423
0.020
Why?
Genome-Wide Association Study
1
2010
311
0.020
Why?
Norfloxacin
1
1988
2
0.020
Why?
Aspergillosis
1
2008
33
0.020
Why?
Oxazolidinones
1
1988
15
0.020
Why?
Ciprofloxacin
1
1988
20
0.020
Why?
Polymorphism, Single Nucleotide
1
2010
447
0.020
Why?
Gram-Negative Bacteria
1
1988
51
0.020
Why?
Risk Factors
1
2018
4817
0.020
Why?
Ribosomal Proteins
1
1988
42
0.020
Why?
Safety
1
2008
139
0.020
Why?
Protein Conformation
1
2010
754
0.020
Why?
Cryptococcus neoformans
1
2008
141
0.020
Why?
Double-Blind Method
1
2008
639
0.020
Why?
Logistic Models
1
2010
1243
0.020
Why?
Disease Progression
1
2010
923
0.020
Why?
Models, Molecular
1
2010
1108
0.020
Why?
CD8-Positive T-Lymphocytes
1
2010
621
0.020
Why?
Tuberculin Test
1
2004
10
0.020
Why?
Immunity, Innate
1
2010
754
0.020
Why?
Cohort Studies
1
2010
2342
0.020
Why?
Risk-Taking
1
2004
157
0.010
Why?
Universities
1
2004
148
0.010
Why?
Attitude to Health
1
2004
278
0.010
Why?
Animals
1
2020
19175
0.010
Why?
Prevalence
1
2004
1247
0.010
Why?
Reverse Transcriptase Inhibitors
1
2000
29
0.010
Why?
CD4 Lymphocyte Count
1
2000
91
0.010
Why?
Vancomycin
1
1999
32
0.010
Why?
DNA Primers
1
2000
294
0.010
Why?
Reference Values
1
2000
326
0.010
Why?
Mass Screening
1
2004
626
0.010
Why?
Lymphocytes
1
2000
192
0.010
Why?
RNA, Viral
1
2000
261
0.010
Why?
Virus Replication
1
2000
284
0.010
Why?
Risk Assessment
1
2004
1835
0.010
Why?
Aminoglycosides
1
1992
8
0.010
Why?
Lactams
1
1992
14
0.010
Why?
United States
1
2004
7263
0.010
Why?
Daly's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (209)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_